The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,7-dimethyl-10-phenylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione ID: ALA503817
PubChem CID: 12668830
Max Phase: Preclinical
Molecular Formula: C19H15N3O2
Molecular Weight: 317.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2c(c1)cc1c(=O)n(C)c(=O)nc-1n2-c1ccccc1
Standard InChI: InChI=1S/C19H15N3O2/c1-12-8-9-16-13(10-12)11-15-17(20-19(24)21(2)18(15)23)22(16)14-6-4-3-5-7-14/h3-11H,1-2H3
Standard InChI Key: DTIGSBAAKFKVDO-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
15.8654 -8.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5815 -8.0846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5786 -7.2545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8636 -6.8457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1510 -8.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1552 -7.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4450 -6.8434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4367 -8.4972 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7221 -8.0779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7227 -7.2476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0081 -6.8342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2880 -7.2464 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2874 -8.0768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0067 -8.4948 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5725 -8.4877 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0099 -6.0097 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2910 -6.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4337 -9.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7175 -9.7279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7142 -10.5517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4273 -10.9674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1452 -10.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1450 -9.7309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5749 -6.8327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
2 3 1 0
9 14 2 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
5 8 1 0
11 16 2 0
6 7 1 0
3 17 1 0
7 10 2 0
8 18 1 0
9 8 1 0
18 19 2 0
9 10 1 0
19 20 1 0
3 4 2 0
20 21 2 0
4 6 1 0
21 22 1 0
5 6 2 0
22 23 2 0
23 18 1 0
1 2 2 0
12 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 317.35Molecular Weight (Monoisotopic): 317.1164AlogP: 2.50#Rotatable Bonds: 1Polar Surface Area: 56.89Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.65CX LogP: 3.03CX LogD: 3.03Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.51Np Likeness Score: -1.01
References 1. Ali HI, Tomita K, Akaho E, Kunishima M, Kawashima Y, Yamagishi T, Ikeya H, Nagamatsu T.. (2008) Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase., 43 (7): [PMID:18055068 ] [10.1016/j.ejmech.2007.10.011 ]